Immuneering Corporation
IMRX
$5.63
-$0.29-4.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.51% | -5.16% | -19.68% | -15.90% | -15.52% |
| Total Depreciation and Amortization | -6.13% | -5.03% | -3.81% | 12.50% | 14.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.02% | 26.52% | 32.25% | 32.05% | 30.44% |
| Change in Net Operating Assets | 353.53% | 66.38% | -10.19% | 17.25% | 2,573.43% |
| Cash from Operations | 18.04% | 9.11% | -23.23% | -12.02% | -7.23% |
| Capital Expenditure | 93.60% | 76.27% | 94.50% | 90.72% | 62.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 66.47% | 77.38% | -45.95% |
| Cash from Investing | -100.04% | -100.04% | 75.26% | 77.41% | -45.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,309.39% | 1,007.69% | 20,295.33% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1,309.39% | -625.64% | 20,295.33% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.00% | -104.05% | -4.94% | 59.63% | -124.67% |